Regeneron Pharmaceuticals, Inc.

NasdaqGS:REGN Stock Report

Mkt Cap: US$85.6b

Regeneron Pharmaceuticals Past Performance

How has Regeneron Pharmaceuticals performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

31.6%

Historical annual earnings growth

Earnings and Revenue History

Past Earnings Growth Analysis

Return on Equity

Return on Assets

Return on Capital Employed

Discover strong past performing companies